ReviewImmune network2018

From Bench to Clinic: the Potential of Therapeutic Targeting of the IL-22 Signaling Pathway in Atopic Dermatitis.

Mirim Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.